Analysts' ratings for Bicycle Therapeutics (NASDAQ:BCYC) over the last quarter vary from bullish to bearish, as provided by 11 analysts.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 7 | 3 | 1 | 0 | 0 |
| Last 30D | 2 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 3 | 2 | 0 | 0 | 0 |
| 3M Ago | 2 | 1 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $41.82, a high estimate of $55.00, and a low estimate of $28.00. Observing a downward trend, the current average is 2.74% lower than the prior average price target of $43.00.
Diving into Analyst Ratings: An In-Depth Exploration
The standing of Bicycle Therapeutics among financial experts is...
Login or create a forever free account to read this news
Sign up/Log in
